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Abstract
Blastocyst formation is essential for implantation and maintenance of pregnancy and is dependent on the expression and
coordinated function of a series of proteins involved in establishing and maintaining the trans-trophectoderm ion gradient
that enables blastocyst expansion. These consist of Na/K-ATPase, adherens junctions, tight junctions (TJ) and aquaporins
(AQP). While their role in supporting blastocyst formation is established, the intracellular signaling pathways that coordinate
their function is unclear. The p38 MAPK pathway plays a role in regulating these proteins in other cell types and is required
for embryo development at the 8–16 cell stage, but its role has not been investigated in the blastocyst.
Hypothesis: p38 MAPK regulates blastocyst formation by regulating blastocyst formation gene expression and function.
Methods: Embryos were cultured from the early blastocyst stage for 12 h or 24 h in the presence of a potent and specific
p38 MAPK inhibitor, SB 220025. Blastocyst expansion, hatching, gene family expression and localization, TJ function and
apoptosis levels were analyzed.
Results: Inhibition of the p38 MAPK pathway reduced blastocyst expansion and hatching, increased tight junction
permeability, affected TJP1 localization, reduced Aqp3 expression, and induced a significant increase in apoptosis.
Conclusion: The p38 MAPK pathway coordinates the overall events that regulate blastocyst formation.
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Introduction
Mammalian preimplantation development extends from fertil-
ization to implantation and culminates in the formation of a
blastocyst, a fluid filled structure that emerges from the zona
pellucida and implants into the uterine wall to maintain pregnancy
[1,2]. The early blastocyst consists of two cell types, the inner cell
mass (ICM) and the trophectoderm (TE) [1,2]. The ICM is an
undifferentiated mass of cells that will become the embryo proper.
The TE is a polarized epithelial cell layer which surrounds the
ICM. The TE mediates implantation to the uterine wall,
contributes to the embryonic portion of the placenta and is
characterized by the expression of transcription factors (TF), such
as caudal homeobox two (Cdx2) [3]. Functional adherens junctions
(AJ) and tight junctions (TJ) form a seal between the cells of the
TE, which is essential for fluid accumulation and formation of the
blastocyst cavity [4–12].
The Na/K ATPase is also a critical mediator of blastocyst
formation as it establishes a trans-trophectoderm ionic gradient
that directs fluid movement across the TE epithelium [13–18].
The Na/K ATPase is comprised of two main subunits; the alpha
(ATP1A) and the beta (ATP1B). Loss of Atp1a during preimplan-
tation development does not impede the initial formation of a
blastocyst, but shortly after results in an embryonic lethality during
peri-implantation development [19]. In contrast, loss of Atp1b1
results in a developmental arrest at the morula stage, and
blastocyst expansion does not occur [18]. Additionally, the Na/
K ATPase acts as a ouabain mediated signaling molecule that
regulates TJ formation and function in the TE [8,12]. Fluid
movement across the TE is facilitated by the presence of
aquaporins (AQP) 3 and AQP 9 in the TE membrane [19].
AQP 9 is localized to the apical surface of the TE and AQP 3 is
localized to the baso-lateral surface of the TE, and together, they
facilitate fluid movement from the ‘outside’ to the ‘inside’ of the
blastocyst cavity, along the ionic gradient established by the baso-
laterally localized Na/K ATPase [19].
Together, the AJs, TJs, Na/K ATPase and AQPs, are critical
gene products that coordinate blastocyst expansion and blastocyst
cavity formation (reviewed in [2]). Although the cell biology of
blastocyst formation is well documented, the molecular signaling
events, particularly the intracellular signaling events, governing
blastocyst formation are unclear (reviewed in [2,20]). The p38
MAPK pathway is an intracellular signaling pathway that
translates extracellular stimuli into cellular responses [21]. This
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intracellular signaling pathway directs a wide variety of physio-
logical processes through Serine/Threonine phosphorylation [21].
p38 MAPK is ubiquitously expressed in all eukaryotic cells and
regulates gene expression, mitosis, migration and apoptosis [21–
25]. Each component of the p38 MAPK pathway is present
throughout preimplantation development and the p38 MAPK
pathway plays both developmental and adaptive roles during
preimplantation development [22,25–27]. Our previous studies
have demonstrated that p38 MAPK is both an important mediator
of early preimplantation development and is also a component of
the adaptive mechanism the embryo can employ to adjust to
environmental influences during development [22,25–27]. p38
MAPK is a gene family consisting of four different isoforms, a, b, c
and d [21]. Our previous studies focusing on the role of p38
MAPK during preimplantation development demonstrated that
treatment of 2-, 4- and uncompacted 8-cell embryos with the
cytokine suppressive anti-inflammatory drugs (CSAIDsTM;
SB203580 and SB220025 active forms; SB202474 inactive form
control) all result in a reversible developmental blockade that
suspends development at the 8–16 cell stage [22,26]. SB203580
and SB220025 are potent and specific pharmacological agents that
are routinely and reliably used to investigate p38 MAPK function
in cell systems (reviewed in [21,28]. We also demonstrated that the
p38 MAPK inhibited blockade is accompanied by a downstream
loss of MAPKAPK2/3 phosphorylation, then loss of HSP25/27
phosphorylation and finally a disassembly of filamentous actin
[22,26]. 8–16 cell stage drug free embryos resume their
developmental program and progress normally to the blastocyst
stage following treatment with an accompanying delay consistent
with the original inhibitor treatment time [22,26].
In addition, the p38 MAPK pathway directs preimplantation
embryonic responses to environmental stress [25,27]. Fong et al.,
2007 reported that MAPKAPK2, a downstream target of p38
MAPK, displayed enhanced phosphorylation in embryos exposed
to hyperosmotic culture medium. This elevation in MAPKAPK2
phosphorylation was extinguished when the embryos were
cultured under hyperosmotic conditions in the presence of SB
220025, demonstrating that p38 MAPK was activated in response
to hyperosmotic stress [27]. Bell et al., 2009 demonstrated that the
p38 MAPK pathway up-regulated Aqp3 and Aqp9 mRNA
expression in response to hyperosmotic stress in 8-cell embryos
but did not regulate blastocyst apoptosis levels resulting from
hyperosmotic stress [25]. Taken together, these results demon-
strate that p38 MAPK signaling regulates both the developmental
program of preimplantation development and embryonic adapta-
tions to environmental stress.
The present study was conducted to investigate the role of p38
MAPK in regulating cavitation and blastocyst formation. Embryos
were cultured from the early blastocyst stage for 12 h or 24 h in
the presence of a p38 MAPK inhibitor, SB 220025. Blastocyst
expansion, zona hatching, TE formation and function, and
apoptosis levels were assessed. We have demonstrated that the
p38 MAPK pathway is required for blastocyst expansion and
hatching and for regulating TJ function. Furthermore, suppression
of p38 MAPK signaling resulted in a significant increase in
apoptosis levels. These results demonstrate that p38 MAPK also
exerts its influences on blastocyst formation and suggests that it is
an important mediator of blastocyst formation gene family
expression, function and thus coordination of the overall events
that regulate blastocyst formation.
Results
Reduced expansion and hatching in p38 MAPK inhibited
embryos
We first defined the concentration and time course effects of
treating early blastocysts with the p38 MAPK inhibitor SB 220025
(Figure 1A). Embryos cultured in all tested concentrations of SB
220025 did not display a significant difference from control
embryos following 4 h and 8 h of treatment (data not shown).
After 12 h of treatment, embryos cultured in 5 mM SB 220025
(diameter, 48.99 microns 60.88 microns), 10 mM SB 220025
(49.77 microns 60.67 microns) or 20 mM SB 220025 (49.41
microns 60.30 microns) displayed a significant reduction in
blastocyst diameter compared to control groups: KSOMaa +0.2%
DMSO (54.87 microns 60.62 microns), KSOMaa +20 mM SB
202474 (inactive analogue of SB 220025) (53.20 microns 62.37
microns). After 24 h of culture, embryos cultured in 2 mM SB
220025 (52.68 microns 62.04 microns), 5 mM SB 220025
(52.31microns 61.18 microns), 10 mM SB 220025 (50.57 microns
62.12 microns) or 20 mM SB 220025 (47.01 microns 60.84
microns) all displayed a significant reduction in blastocyst diameter
compared to control groups: KSOMaa +0.2% DMSO (61.14
microns 61.34 microns), KSOMaa +20 mM SB 202474 (64.04
microns 60.56 microns) (Figure 1; Figure S1). From these data,
we selected 5 mM SB 220025 as the lowest effective concentration
for investigating the effects of p38 MAPK inhibition on blastocyst
formation and used this concentration in all subsequent experi-
ments. To validate the specificity and reproducibility of these
outcomes, we repeated this experiment using a second p38 MAPK
inhibitor, SB 203580. Our outcomes employing 5 mM SB 203580
for 24 h were identical to the SB 220025 outcomes in that we
observed a significant reduction in blastocyst diameter in the
presence of SB 203580 (Figure S2). To ensure the effects we were
observing were not being mediated by inadvertently affecting the
ERK MAPK pathway, we probed embryos treated for 24 h with
5 mM SB 220025 for total-ERK and phospho-ERK levels by
immunofluorescence. Treatment with SB 220025 had no observ-
able influence on total or phospho-ERK fluorescence levels
(Figure S3).
After 12 h and 24 h of treatment, embryos were washed
extensively in fresh, drug free medium and then placed into fresh
culture drops for a treatment recovery period. Embryos treated for
12 h and then placed into recovery medium remained significantly
less expanded than controls; however, they did resume expansion
and continued to expand for the full recovery period (Figure 1B).
Embryos treated for 24 h with SB 220025 did not resume
blastocyst expansion following this treatment (Figure 1C).
As we established that p38 MAPK signaling regulates blastocyst
expansion, we next investigated the role of p38 MAPK signaling in
blastocyst hatching in vitro. Zona hatching was assessed at 24 h and
48 h post collection. Blastocysts treated for 12 h (Figure 1D) with
SB 220025 displayed reduced zona hatching (4%64%) compared
to KSOMaa (20%615%) and SB 202474 (24%610%) controls at
24 h post collection. Blastocysts treated for 24 h (Figure 1E) with
SB 220025 (0%) displayed a significant (p#0.05) reduction in zona
hatching compared to controls; KSOMaa (22%612%) or SB
202474 (31%610%). Extending the experimental period to 48 h
post collection (i.e. 12 h or 24 h treatment followed by 36 h or
24 h recovery respectively), had no benefit as embryos treated with
SB 220025 remained enclosed by the zona pellucida (data not
shown).
p38 MAPK Regulates Blastocyst Cavitation
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Blastocyst expansion failure is accompanied by increased
TJ permeability and disrupted localization of Tjp1
Since p38 MAPK inhibition resulted in reduced blastocyst
expansion, we wanted to investigate whether this was linked to
impaired TE differentiation or improper TE polarization
(Figure 2). To assess TE differentiation, we investigated the
expression of CDX2, a TF that is required for TE lineage
specification [3]. CDX2 localization was maintained and confined
to the outer cells (yellow arrows) of both control and SB 220025
treated blastocysts (Figure 2A). To investigate TE polarization, we
characterized the localization of CDH1, which is normally
localized to the basolateral membranes of the TE (reviewed in
[2,20]). CDH1 maintained a normal, basolateral cell margin
distribution pattern in the TE cells in each treatment group
(Figure 2B). These results support the conclusion that TE
differentiation and polarization were not affected by treatment
with SB 220025.
p38 MAPK Inhibition Compromises TJ Permeability
Since blastocyst cavitation was reduced in p38 MAPK inhibited
embryos, we next sought to investigate whether TE permeability
was compromised in SB 220025 treated embryos. We investigated
effects of SB 220025 treatment on TJ permeability using a
standard FITC-dextran assay (Figure 3) [8,12]. Blastocyst expan-
sion is dependent upon the formation of a TJ permeability seal in
the TE (reviewed in [2,20]). Changes in the permeability of this TJ
seal can be precisely assessed by applying a sensitive FITC-
Dextran assay [8,34]. Following 12 h (Figure 3A) and 24 h
(Figure 3B) SB 220025 treatment, we observed a significant
increase in FITC-dextran accumulation into the blastocyst cavity
compared to controls. This demonstrated that p38 MAPK activity
regulates TE TJ permeability. We then assessed effects of
treatment on TJP1 localization. Blastocysts treated for 12 h
(Figure 4A) with SB 220025 displayed abnormal TJP1 cortical
staining compared with control embryos. TJP1 is normally
distributed along the apico-baso membrane in a smooth,
continuous pattern as shown in control embryos cultured in
Figure 1. p38 MAPK Regulates Blastocyst Expansion and Hatching. p38 MAPK inhibition decreased embryo expansion and hatching. (A)
After 12 h and 24 h embryos cultured in KSOMaa + SB 220025 were significantly less expanded than controls. Three replicates were performed and
30–35 embryos were measured in each group. SEM p#0.05; letters (a–c) represent groups that are significantly different from one another. (B–C)
Embryo recovery after 12 h (B) and 24 h (C) treatment of SB 220025. Embryos were washed in fresh KSOMaa after 12 h or 24 h and allowed to recover
until 24 h, 28 h, and 36 h post collection. Embryos treated with SB 220025 for 12 h remained significantly less expanded compared to controls,
however, they resumed cavitation and increased their expansion following treatment. Embryos treated with SB 220025 for 24 h remained
significantly less expanded compared to controls, and were not able to re-expand. Three replicates were performed and 30–35 embryos were
measured in each group. SEM p#0.05; letters (a–c) represent groups that are significantly different from one another. (C) Inhibition of the p38 MAPK
pathway blocked embryo hatching. Embryos cultured in SB 220025 for 12 h or 24 h displayed significantly reduced zona hatching compared to
controls. Embryos were cultured in KSOMaa, SB 202474 or SB 220025 for 12 h and then washed in fresh KSOMaa and cultured until 24 h post
collection and assessed for hatching. Embryos that had begun to hatch were counted as positive (SEM; p#0.05; n=4).
doi:10.1371/journal.pone.0059528.g001
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KSOMaa or SB202474 (Figure 4A). TJP1 also co-localizes with
the cytoskeleton, which can be observed as a yellow signal in the
merged images of both KSOMaa and SB 202474 treated embryos
(Figure 4A; KSOMaa merged image; SB 202474 merged image).
In p38 MAPK inhibited embryos, TJP1 appears in tight foci at
cell-cell contacts with punctate staining and there is a loss of yellow
co-localization signal revealing a predominantly red signal,
indicative of F-actin signal alone and a loss of TJP1 co-localization
(Figure 4A; SB220025 merged image). The same punctate
distribution along the apico-baso membrane and loss of yellow
co-localization signal was observed in embryos treated after 24 h
(Figure 4B) of p38 MAPK inhibition. After 24 h, TJP1 localization
was considerably more punctate along adjacent cell borders in SB
220025 treated embryos compared to 12 h of treatment and
compared to control embryos. This punctate distribution was
observed in 70% of embryos treated for 12 h and 85% of embryos
treated for 24 h with SB 220025 as scored by two independent
observers.
We then analyzed the effects of blocking p38 MAPK activity on
other genes involved in establishing and maintaining the trans-
trophectoderm ion gradient during blastocyst formation by
applying qPCR. We investigated the effects of SB 220025
treatment on zonula occludens (Tjp1), Occludin (Ocln), and the Na/K
ATPase beta 1-subunit (Atp1b1) mRNA levels [7,8,12,18]. No
significant difference in Tjp1, Ocln, or Atp1b1 mRNA levels were
observed among treatment groups (Figure 5). To complete our
analysis of the effects of p38 MAPK inhibition on blastocyst
formation gene families, we investigated the effects of SB 220025
treatment on Aqp3 and Aqp9 mRNA levels. After 12 h of SB
220025 treatment, there was no significant difference in Aqp3 or
Aqp9mRNA levels between treated and control groups (Figure 6A).
After 24 h, Aqp9 mRNA levels were unaffected; however Aqp3
mRNA levels were significantly (p, 0.05) reduced in embryos
treated with SB 220025 compared to controls (Figure 6A).
Protein staining as observed using confocal microscopy also
revealed a similar pattern. Embryos treated for 12 h had little or
no difference in AQP3 localization (data not shown). However,
embryos treated for 24 h displayed an obvious and consistent
reduction in AQP3 immunofluorescence intensity in p38 MAPK
inhibited embryos (Figure 6B). AQP9 staining did not reveal any
visible difference after either 12 h or 24 h time point (data not
shown).
Inhibition of p38 MAPK Signaling Increases Apoptosis in
the Blastocyst
The results indicate that p38 MAPK regulates blastocyst
expansion, zona hatching in vitro, TJ permeability, TJP1 localiza-
tion and Aqp3 mRNA levels. The timing of p38 MAPK inhibition
is critical as 12 h treated embryos recovered from treatment as
demonstrated by their resumption of cavitation following treat-
ment and placement in drug free culture medium, while 24 h
treated embryos did not recover from treatment. We thus
Figure 2. TE formation and apico-basal cell polarity in TE appear normal in p38 MAPK inhibited embryos. CDX2 protein localization (A)
following 24 h of treatment with KSOMaa, SB 202474, or SB 220025. White arrows indicate ICM; Yellow arrows indicate TE. Blue = nucleus; Red = F-
actin; Green = CDX2; n = 10–15 embryos in each group; scale bar = 10 microns. CDH1 protein localization (B) following 24 h of treatment with
KSOMaa, SB 202474, or SB 220025. CDH1 protein localization pattern did not vary after 24 h. Blue = nucleus; Red = F-actin; Green = CDH1; n= 10–
15 embryos in each group; scale bar = 10 microns.
doi:10.1371/journal.pone.0059528.g002
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investigated whether embryos treated for 24 h with SB 220025
were unable to recover due to increased induction of apoptosis.
Blastocysts treated for 12 h with SB 220025 displayed no
significant difference in apoptosis levels between groups
(Figure 7A). However, embryos cultured for 24 h in SB 220025
displayed a significant (P,0.05) increase in apoptotic cells (11%
61%, Figure 7A; representative images display in Figure 7B) over
that observed for controls (KSOMaa (6% 61%) and SB 202474
(6%62%).
Discussion
Preimplantation development is the most vulnerable period of
mammalian development with the majority of human preimplan-
tation embryos failing to reach the blastocyst stage or implant [35].
With the increasing reliance on fertility clinics and Assisted
Reproductive Technologies (ARTs) to provide patients with an
opportunity to have children [36–38], research focusing on
understanding the mechanisms controlling preimplantation devel-
opment and also on how the environment affects that develop-
mental program is increasingly needed.
The Na/K-ATPase subunits, AJs, TJs and AQPs contribute
directly to the mechanism that enables the TE to oversee
cavitation and blastocyst formation (reviewed in [12,25]. It is
necessary to define the intracellular signaling mechanisms that
regulate the functions of these gene products so that we can
develop a comprehensive understanding of how cavitation and
blastocyst formation are coordinated. The present study, with its
focus on p38 MAPK, probed the role of this pathway and its
contributions to cavitation and blastocyst formation.
We have demonstrated that p38 MAPK regulates cavitation
and overall blastocyst formation. p38 MAPK inhibition in early
blastocysts is accompanied by an increase in TJ permeability, shifts
in TJP1 localization, down regulation of Aqp3 mRNA levels,
reduced AQP3 localization and increased apoptosis. These
outcomes place p38 MAPK as a likely intracellular signaling
mediator that coordinates the function of proteins involved in
establishing the trans-trophectoderm ionic gradient during blasto-
cyst formation. The consistency of outcomes observed regarding
the effects to blastocyst cavity expansion for both p38 MAPK
inhibitor treatments employed in this study, and the absence of
observable effects to the ERK MAPK pathway during these
treatments, support our conclusion that the effects we have
observed are specifically attributable to a blockade of p38 MAPK
activity and are not due to off-target effects from the inhibitors.
Gene deletion studies have demonstrated that p38 MAPK a is
required for successful development with knockout mice suffering
a developmental lethality by day 10.5 of pregnancy (reviewed in
[39]). Each p38 MAPK inhibitor compound targets both p38
MAPK a and b forms and thus while preimplantation embryos
may be able to complete this developmental interval in the absence
of p38 MAPK a, we would suggest that our collective results
demonstrate that targeting both p38 MAPK a and b using p38
MAPK inhibitors results in a cessation of preimplantation
development and erosion of the adaptive mechanisms that early
embryos use to adjust to the environment [22,25–28]. This could
Figure 3. p38 MAPK inhibition compromises TJ integrity. To test TJ integrity, embryos were treated in KSOMaa, SB 202474, or SB 220025 then
exposed to 40 kDa FITC-dextran. After 12 h of treatment (A), a significant difference was observed in the number of embryos displaying 40 kDa FITC-
dextran fluorescence within the blastocyst cavity between SB 220025 and control groups (p#0.05) n = 3. After 24 h of treatment (B), a significant
difference was observed in the number of embryos displaying 40 kDa FITC-dextran fluorescence within the blastocyst cavity between SB 220025 and
control groups (p#0.05) n = 3. Representative images of embryos following 12 h or 24 h treatment with (C) 2 mM EGTA (positive control), (D)
KSOMaa, (E) SB 202474 or (F) SB 220025 using 40 kDa FITC-dextran. n=3; 6 SEM; scale bars = 10 microns.
doi:10.1371/journal.pone.0059528.g003
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indicate that p38 MAPK a and b may play overlapping or
redundant roles during preimplantation embryonic development.
We were concerned that the outcomes on blastocyst expansion
following p38 MAPK inhibition may be related to effects on TE
differentiation or polarity. CDX2 activity is regulated by p38
MAPK phosphorylation in intestinal epithelial cell differentiation
[40] and, p38 MAPK regulates Cdh1 expression during gastrula-
tion [41–43]. We therefore sought to determine if p38 MAPK
regulated CDX2 and CDH1 localization in the blastocyst. We
demonstrated no effect of p38 MAPK inhibition on CDX2 or
Figure 4. Inhibition of p38 MAPK affects TJP1 localization after 12 h and 24 h. TJP1 protein localization following treatment with KSOMaa,
SB 202474, or SB 220025. Representative images of TJP1 after 12 h (A) and 24 h (B) exposure. SB 220025 treatment affected TJP1 localization after
12 h (A) and 24 h (B). In KSOMaa and SB 202474 images, white arrows indicate normal localization of TJP1 along adjacent cell borders. In p38 MAPK
inhibited images, white arrows indicate punctate distribution of TJP1 compared to control embryos. In control embryos, yellow staining indicates co-
localization of TJP1 and F-actin (yellow arrowhead). In treated embryos, there is reduced yellow staining, and increased red staining indicating a loss
of co-localization of TJP1 and F-actin (yellow arrowhead). Blue = nucleus; Red = F-actin; Green = TJP1; n= 10–15 embryos in each group; scale bar
= 10 microns.
doi:10.1371/journal.pone.0059528.g004
Figure 5. p38 MAPK inhibition does not affect mRNA expression of Tjp1, Atp1b1, or Occludin. q-PCR was utilized to determine mRNA
expression levels of Tjp1, Atp1b1, and Occludin. There was no significant difference in mRNA expression levels between treatment groups. (n= 4,
mean 6 SEM).
doi:10.1371/journal.pone.0059528.g005
p38 MAPK Regulates Blastocyst Cavitation
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e59528
CDH1 localization suggesting that TE differentiation and polarity
were well established and likely unaffected by the p38 MAPK
inhibition. It may be possible that p38 MAPK does affect TE
differentiation and TE polarity but to determine this, experiments
would have to be directed to earlier stages, prior to the onset of
cavitation. The maintenance of TE differentiation and polarity
ensure that the outcomes observed pertain specifically to p38
MAPK regulation of cavitation and are not due to disruption of
TE differentiation or polarity.
We also concluded that F-actin was present and properly
localized in p38 MAPK inhibited embryos. We did not observe
any changes in staining intensity of F-actin in p38 MAPK
inhibited blastocyst unlike those reported by Natale et al. 2004 and
Paliga et al., 2005. Natale et al., 2004, and Paliga et al., 2005,
demonstrated that p38 MAPK signaling was required at the 8–16
cell stage for normal blastocyst development through its regulation
of heat-shock protein 25/27 which stabilizes F-actin. F-actin
stability was restored after p38 MAPK inhibition was removed and
embryos were able to progress to the blastocyst stage [22,26]. The
differences we have observed between our two studies could
indicate a stage specific role that p38 MAPK plays at the 8–16 cell
stage versus the blastocyst stage. This result may have revealed a
developmental maturation that p38 MAPK undergoes as the
embryo advances towards the blastocyst stage and prepares for
implantation.
We observed an effect of p38 MAPK inhibition treatment time
on blastocyst cavitation and zona hatching. Both a 12 h and 24 h
treatment time had a significant negative effect on blastocyst
cavitation and zona hatching in vitro. Embryos treated for 12 h
displayed an ability to resume expansion after treatment while
those treated for 24 h did not. Both treatment times resulted in a
blockade of zona hatching in vitro even after placement in fresh
culture drops and allowed to recover. Our interpretation of these
outcomes is that the 12 h treatment slowed down the develop-
mental program sufficiently to prevent the embryos from fully
catching up to controls, which had hatched, during the recovery
period. This outcome mirrors our observations of the effects of p38
MAPK inhibition treatment on cleavage stage embryos, where
they proceeded to the blastocyst stage in normal frequencies once
p38 MAPK inhibition treatment is removed, albeit in a delayed
fashion [22,26]. Alternatively, we suggest that the 24 h treatment
was long enough to deprive the embryo its adaptive mechanism to
respond to environmental stress resulting in an inability of the
embryo to recover (Reviewed in [21,22,25–27,39]. The down
regulation of Aqp3 mRNA levels and reduced AQP3 detection
observed only at the 24 h treatment time is certainly consistent
with this interpretation of our results. A decline in Aqp3 mRNA
levels and reduced AQP3 detection are suggestive that facilitated
fluid movement across the TE may be impeded by 24 h p38
MAPK inhibition treatment. If so, this would certainly contribute
to the inability of 24 h p38 MAPK inhibition treated embryos to
resume expansion and is consistent with our earlier report that p38
MAPK regulates Aqp mRNAs levels in cleavage stage embryos
[25]. Apoptosis was unaffected by the 12 h p38 MAPK inhibition
Figure 6. Inhibition of p38 MAPK affects Aqp3mRNA expression and protein localization. (A) Relative Aqp 3 and 9 mRNA levels following
treatment. qRT–PCR was used to determine the relative mRNA levels of Aqp 3 after 12 h or 24 h in SB 220025. Aqp 3 and Aqp 9 mRNA was not
significantly affected after 12 h; n= 3, mean 6 SEM, P#0.05. Aqp 9 mRNA was not significantly affected after 24 h; however, Aqp 3 mRNA was
significantly decreased after 24 h. Each group is expressed relative to KSOMaa control. n= 3, mean 6 SEM, P#0.05. (B) AQP3 immunofluorescence
after 24 h of p38 MAPK inhibition. AQP3 protein localization following treatment with KSOMaa, SB 202474, or SB 220025. Embryos treated with SB
220025 for 24 h displayed a clear and consistent reduction in AQP3 immunofluorescence compared to controls. Green =AQP3; n= 10–15 embryos in
each group; scale bar = 10 microns.
doi:10.1371/journal.pone.0059528.g006
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treatment period, but the 24 h treatment period was accompanied
by a significant increase in apoptosis. Studies have demonstrated
that it is the JNK/SAPK pathway that regulates apoptosis in the
preimplantation embryo, especially following environmental stress
[25,44–46].We propose that failure to resume cavitation, increased
apoptosis, and the loss of AQP3 are reflective of the effects of
environmental stress on the embryo due to the prolonged
inhibition of the p38 MAPK pathway [25,27].
Finally, the increased FITC-dextran permeability we observed
following p38 MAPK inhibition treatment is consistent with our
earlier studies [8,12]. Loss of p38 MAPK signaling during EMT
resulted in disorganized and loss of expression of TJP1 in human
mesothelial cells [47]. Collectively, these studies provide an
understanding of the mechanisms that control TJ function during
cavitation and reinforce our understanding of the role the TJ
permeability seal plays in regulating cavitation and blastocyst
formation [8,12,18]. In conclusion, our results support an
important role for p38 MAPK in mediating cavitation and
blastocyst expansion and suggest that it regulates blastocyst
formation gene family expression, function and thus coordination
of the overall events that control blastocyst formation.
Materials and Methods
Ovulation Induction and Mouse Embryo Collection
Female MF-1 mice (Charles River, Canada; 3–5 weeks old)
were injected with 5 IU Pregnant Mare’s Serum Gonadotropin
(PMSG)(Intervet Canada Ltd, Whitby, Ontario, Canada), fol-
lowed by 5 IU human Chorionic Gonadotropin (hCG) (Intervet)
48 h later and mated with CD-1 males. Successful mating was
determined the following morning (Day 1) by the detection of a
vaginal plug. Time post-hCG was used to measure the develop-
mental stage of the embryos. Preimplantation mouse embryos
were flushed from the reproductive tract using M2 flushing media
(Sigma, St Louis, MO, USA) at 89 h (early blastocyst) post-hCG.
All animal care and embryo collection methods were conducted
using approved protocols from the Canadian Council of Animal
Care and the University of Western Ontario Animal Care and
Veterinary Services. The approved University of Western Ontario
animal care protocol number for these studies is 2010-021Watson.
Embryo Culture and Treatment
Concentration Response Experiments. Embryos were
washed four to five times in 50 ml drops of either potassium
simplex optimized medium with amino acids (KSOMaa, Chemi-
con, Temecula, CA, USA) +0.2% dimethylsulfoxide (DMSO),
KSOMaa +20 mM SB 202474 (inactive analogue control),
KSOMaa + 2 mM SB 220025, KSOMaa + 5 mM SB 220025,
KSOMaa +10 mM SB 220025 or KSOMaa + 20 mM SB 220025
and transferred to 20 ml drops of the respective treatment under
light paraffin oil. They were maintained in culture under 5% CO2
in air atmosphere at 37uC for 24 h. Embryos were imaged at 4 h,
8 h, 12 h and 24 h post collection. After 12 h or 24 h of
treatment, embryos from each group were washed in fresh
KSOMaa (minimum of 3 times) and placed in fresh KSOMaa
20 ml culture drops for recovery experiments. Embryos were
imaged at time points equivalent to 24 h, 28 h and 36 h post
embryo collection. These time points are equivalent to 12 h, 16 h
and 24 h of recovery for 12 h treated embryos and 4 h and 12 h
recovery for 24 h treated embryos respectively (Figure S4).
Figure 7. Prolonged inhibition of p38 MAPK increased apoptosis. (A) Apoptosis following KSOMaa, SB 202474 or SB 220025 treatment for
12 h and 24 h. TUNEL was used to assess the level of apoptosis in blastocysts after having been cultured in KSOMaa, SB 202474 or SB 220025 media
for 12 h or 24 h. The number of individual cells that were TUNEL positive was counted in each blastocyst and is represented as the average number
of cells that are TUNEL positive per blastocyst. Embryos cultured in KSOMaa, SB 202474 or SB 220025 for 12 h displayed the same average number of
TUNEL positive cells. Embryos cultured in SB 220025 for 24 h displayed a significant increase in the average number of TUNEL positive cells compared
with controls; mean 6 SEM, P#0.05. (B) Representative images of embryos from TUNEL assay. Negative: No fluorescence control; Positive: Embryos
pretreated with DNAse to ensure TUNEL staining was successful. n= 4 replicates; 15–20 embryos in each group.
doi:10.1371/journal.pone.0059528.g007
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Embryo diameter was used to assess blastocyst expansion.
Diameter of each blastocyst was measured in two different
directions (using Image Pro analysis 6.2 software; Figure S5) and
then averaged. To confirm expansion results from embryos treated
with SB 220025, embryos were also treated with 5 mM SB 203580,
a second potent p38 inhibitor, for 24 h and measured.
Assessment of Zona Hatching In Vitro. Embryos were
washed four to five times in 50 ml drops of treatment medium and
transferred to 20 ml drops of the respective treatment medium
under light paraffin oil. They were maintained in culture under
5% CO2 in air atmosphere at 37uC for 12 h or 24 h. Embryo
hatching was assessed at 24 h and 48 h post collection. An embryo
was considered to be ‘‘hatching’’ if any part of the embryo
protruded from the zona pellucid, or ‘‘hatched’’ if the embryo was
completely free of the zona pellucida. Four replicates were
performed.
Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) was conducted to determine
the effects of p38 MAPK inhibition on the mRNA levels of TE
associated proteins. Total RNA was extracted from pools of 20
embryos using the PicoPure kit (Arcturus, Molecular Device,
Sunnyvale, CA). Reverse Transcription (RT) reaction was carried
out using Sensiscript reverse transcriptase (Qiagen, Mississauga,
ON). The samples were incubated in 10x buffer, RNAse inhibitor,
dNTPs and random primers at 37uC for 1 h. Q RT-PCR
reactions were performed using the BioRad Chromo4 detection
system (BioRad, Mississauga, ON). PCR was carried out in 20 ml
reactions containing 10 ml SYBR Green (Invitrogen, Burlington,
ON), 0.2 ml of primer sets provided by Biosearch Technologies
(Novado, CA), 1 ml of appropriate dilution of cDNA (1 embryo/
ml), and 8.8 ml of water. To confirm the specificity of each
quantitative RT-PCR product, amplicons were extracted from
gels and purified using a QIAquick gel extraction kit (Qiagen,
Mississauga, ON) and submitted for nucleotide sequencing (DNA
Sequencing Facility, Robarts Research Institute, London, ON,
Canada). The nucleotide sequences were then compared with
sequences available in GenBankTM nucleotide sequence data
base, and in all cases the specificity of each PCR product was
confirmed. Aqp3 and Aqp9 were obtained from Applied Biosystems
(Aqp3Assay ID: mm01208559_m1; Aqp 9 Assay ID:
mm00508094_m1). All other sequences can be found in
Figure S6. Three to six replicates were performed.
Antisera
Antibodies used in whole mount immunofluorescence proce-
dures were obtained from commercial sources: CDH1 and TJP1
(Upstate Cell Signaling Solutions, Charlottesville, VA), CDX2
(Aviva Systems Biology, San Diego, CA), AQP3 and 9 (Alpha
Diagnostic Int. (San Antonio, TX, USA)), ERK and p-ERK (Cell
Signalling Technologies (Danvers, MA, USA).
Indirect Immunofluorescence
Mouse embryos were collected from the reproductive tracts of
super ovulated female MF-1 mice as described above. Embryo
pools were washed in 1x PBS (GIBCO) and fixed for indirect
immunofluorescence in 2% paraformaldehyde in PBS at room
temperature for 30 minutes. Fixed embryos were washed once in
16PBS and either used immediately or stored at 4uC in embryo
storage buffer (16 PBS +0.1% sodium azide) for up to 1 week
before processing for whole-mount indirect immunofluorescence
as previously described [16,18,27,29,30]. Fixed embryos were
permeabilized in blocking buffer (0.01% Triton X-100 +5%
normal donkey serum in 16 PBS) at room temperature for 1 h
followed by two washes in fresh PBS. Embryos were incubated
with primary antibody in a 1:100 dilution in antibody dilution/
wash buffer (ADB; 0.005% Triton X-100 +0.5% normal donkey
serum in 16 PBS) at 4uC overnight. Negative controls included
embryos incubated in ADB alone without the addition of the
primary antibody in order to determine the levels of non-specific
fluorescence. Embryos were then washed three times for
30 minutes in ADB at 37uC and incubated with fluorescein
isothiocyanate (FITC)-conjugated secondary antibody (1:200 in
ADB) at 4uC overnight, followed by three washes for 30 minutes
in ADB at 37uC. 49,6-diamidino-2-phenylindole (DAPI; Sigma-
Aldrich; diluted 1:2000 from 1 mg/ml stock solution), a nuclear
stain, along with Rhodamine phalloidin (diluted 1:20 into ADB), a
filamentous actin (F-actin) stain, were added to the first wash step.
Fully processed embryos were mounted onto glass slides in 20 ml of
Vectashield mounting medium (Vector, Burlingame, CA) under
elevated 22622 mm glass cover slips (No. 1 thickness), and slide
preparations were sealed with nail polish. Slides were stored for up
to 2 days at 4uC in a light tight box prior to immunofluorescence
imaging. Embryos were examined by confocal microscopy using
an Olympus Fluoview 1000 laser scanning Confocal Microscope
(Olympus, Canada). In total, 10–15 embryos for each treatment
were examined for each of the primary antisera.
Assessment of TJ Function by FITC-Dextran Uptake Assay
To investigate the effects of p38 MAPK inhibition on TJ
permeability, embryos were cultured for 12 h or 24 h in
KSOMaa, SB 202474, SB 220025 or for 30 minutes in 2 mM
EGTA (ethylene glycol Bis- (b-aminoethyl ether) N,N,N,N -
tetraacetic acid). After treatment, blastocysts were cultured in
drops containing 40 kDa FITC-Dextran in KSOMaa for
30 minutes. Following this incubation, blastocysts were immedi-
ately washed in three 50 mL wash drops of KSOMaa and placed
in a fourth clean KSOMaa drop for immediate assessment of
FITC-dextran accumulation employing an epi-fluorescent micro-
scope (Olympus). Three replicates were performed for each time
point.
TUNEL Apoptosis Assay
Cleavage of genomic DNA during apoptosis yields single strand
breaks in high molecular weight DNA, which can be identified by
labeling the free 39-OH terminal with modified nucleotides in an
enzymatic reaction [31,32]. After 24 h of treatment, embryo pools
were fixed for 1 h in 2% paraformaldehyde in PBS and washed in
PBS. Fixed embryos were then permeabilized and blocked for
3 minutes in permeabilization solution (1% sodium citrate +0.01%
Triton X-100) at 4uC. Embryos were then washed in PBS, and a
positive control group was removed from the treatment groups
and treated with 100 ml DNAse solution (10 ml DNAse1 (Invitro-
gen) in 990 ml 50 mM Tris-HCl) for 13 minutes at room
temperature. This was done to induce strand breaks, allowing
for the assessment of maximal DNA fragmentation during
analysis. A group of embryos was removed from the treatment
groups to serve as the negative control group. The positive control
and the treatment groups were placed in 50 ml TUNEL reaction
mixture (terminal deoxynucleotidyl transferase from calf thymus,
recombinant in Escherichia coli, in storage buffer + nucleotide
mixture in reaction buffer). The TUNEL reaction mixture labeled
DNA strand breaks through terminal deoxynucleotidyl transferase,
which catalyzes polymerization of labeled nucleotides to the free
39-OH DNA ends in a template-independent manner, and by
incorporating fluorescein labels in nucleotide polymers [31,33].
Negative control embryos were put into 50 ml TUNEL label
solution (nucleotide mixture in reaction buffer) only. Embryos
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were incubated for 60 minutes in a humidified chamber at 37uC.
The groups were then washed in 0.5 ml DAPI (Sigma-Aldrich;
diluted 1:2000 from 1 mg/ml stock solution) +200 ml PBS for
30 minutes, to stain the DNA. The groups were washed twice
more in 200 ml PBS, for 15 minutes at 37uC. Fully processed
embryos were mounted onto glass slides in a drop of Vectashield
mounting medium. Three replicates were performed for each time
point.
Apoptotic Fluorescence Image Analysis
Embryos were examined by confocal microscopy using an
Olympus Fluoview 1000 laser scanning Confocal Microscope
(Olympus, Canada). Z-stack images were taken of the embryos
and used to count total cell number and FITC positive cell
number. Apoptotic fluorescence was assessed by first counting the
number of DAPI-stained (blue) nuclei, representing the total
number of cells in the early embryo followed by counting the
FITC-stained (green) apoptotic nuclei. To obtain the percent of
apoptotic cells, the number of FITC-stained cells was divided by
the number of DAPI-stained cells. All microscope and image
capture settings remained constant during the digital capture of
micrographs between embryos and between treatment groups. 10–
15 embryos were assessed for each treatment group.
Statistical Analysis
The results from the concentration response and recovery
experiments were first subjected to Normality tests and once
passed, analyzed by a repeated measure ANOVA test followed by
a Student-Newman-Keuls post hoc test. All other experiments
were also first subjected to Normality tests and once passed,
analyzed by a one-way ANOVA test followed by a Student-
Newman-Keuls post hoc test. All error bars represent standard
error mean (SEM). Significant p value #0.05. Data was analyzed
using the SigmaStatH 3.5 (Jandel Scientific Software, San Rafael,
CA, USA).
Supporting Information
Figure S1 Representative images of embryos from each
treatment group at each time point during the recovery
experiment. Scale bar = 20 microns.
(TIF)
Figure S2 Embryos were cultured for 24 h in control media
(KSOMaa and SB 202474) or in KSOMaa + SB 203580 and
imaged at 0 h, 12 h, and 24 h of treatment. The diameter of each
embryo was measured as described in Figure S5. After 24 h
embryos cultured in SB 203580 were significantly less expanded
than controls. Three replicates were performed and 15–20
embryos were measured in each group. 6 SEM; p#0.05.
(PDF)
Figure S3 Total-ERK and phospho–ERK protein following
treatment with KSOMaa, SB 202474, or SB 220025 using
immunofluorescense. Representative images of total-ERK after
24 h of treatment KSOMaa (A), SB 202474 (B) or SB 220025 (C)
and phospho-ERK after 24 h of treatment KSOMaa (D), SB
202474 (E) or SB 220025 (F). There was no visible difference
between total-ERK or phospho-ERK between the treatment
groups. Green = total-ERK (A–C); Green = phosphor-ERK (D–
F); No primary (G) n=10–15 embryos in each group; scale bar
= 10 microns.
(TIF)
Figure S4 Timeline for embryo collection, treatment time, and
recovery time for all experiments. Embryos were collected at 89 h
post hCG and cultured for 12 h or 24 h. Embryos were imaged
and measured at 0 h, 4 h, 8 h, 12 h, and 24 h post hCG, and
again following recovery, at 24 h, 28 h and 36 h post hCG.
Embryos were collected at 12 h or 24 h and either analyzed for
RT-PCR, FITC assay, TUNEL assay or immunofluorescense or
placed into fresh culture drops and allowed to recover. Hatching
was assessed at 24 h post hCG.
(TIF)
Figure S5 Embryo diameters were measured for dose response
and recovery experiments. Embryos were measured in two
different directions and then averaged.
(TIF)
Figure S6 Quantitative RT-PCR primer sets.
(TIF)
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